Matt Perlberg
President, Pharmacy and Care Delivery, Evernorth Health Services
About
Matt Perlberg is President of the Evernorth Health Services® pharmacy and care delivery businesses, which include Accredo® specialty pharmacy, CuraScript SD, Evernorth Home-Based Care, Express Scripts Pharmacy®, and MDLIVE, among others. Matt is a member of the Enterprise Leadership Team of The Cigna Group.
Under Matt’s direction, these industry-leading businesses provide a best-in-class experience for patients and providers across multiple sites of care and channels. These businesses remain relentlessly focused on delivering exceptional patient care.
Matt joined Evernorth in 2013 and has held various leadership roles within the organization’s pharmacy, corporate strategy and supply chain teams. He is a seasoned leader with deep expertise across health care strategy, drug sourcing, supply chain management and more. He also has extensive experience in bringing new product solutions to market.
Matt currently serves on the board of the Crohn’s and Colitis Foundation’s Mid-America Chapter, which is dedicated to finding the cures for Crohn's disease and ulcerative colitis.
He earned a bachelor’s degree from Washington University in St. Louis, and an MBA with high distinction from Harvard Business School.
Under Matt’s direction, these industry-leading businesses provide a best-in-class experience for patients and providers across multiple sites of care and channels. These businesses remain relentlessly focused on delivering exceptional patient care.
Matt joined Evernorth in 2013 and has held various leadership roles within the organization’s pharmacy, corporate strategy and supply chain teams. He is a seasoned leader with deep expertise across health care strategy, drug sourcing, supply chain management and more. He also has extensive experience in bringing new product solutions to market.
Matt currently serves on the board of the Crohn’s and Colitis Foundation’s Mid-America Chapter, which is dedicated to finding the cures for Crohn's disease and ulcerative colitis.
He earned a bachelor’s degree from Washington University in St. Louis, and an MBA with high distinction from Harvard Business School.